| Pomalidomide Combined With Obinutuzumab in the Treatment of Patients With Relapsed/Refractory Indolent Lymphoma (NCT07441954) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-20 |
| A Clinical Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Premature Ovarian Insufficiency (NCT07510139) | International Peace Maternity and Child Health Hospital | 2026-03-20 |
| A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN） (NCT07496073) | Tianjin Medical University Cancer Institute and Hospital | 2026-03-20 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects. (NCT07521345) | Haisco Pharmaceutical Group Co., Ltd. | 2026-03-20 |
| A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults (NCT07455084) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2026-03-20 |
| Single Ascending Dose Study of HB2198 in Healthy Participants (NCT07439263) | Hinge Bio | 2026-03-19 |
| A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects (NCT07446153) | Jiangsu HengRui Medicine Co., Ltd. | 2026-03-19 |
| A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 (NCT07390955) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-03-19 |
| A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants (NCT07241065) | AstraZeneca | 2026-03-19 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants (NCT07448155) | Incyte Corporation | 2026-03-19 |
| Study in Advanced Solid Tumor Patients (NCT07300943) | Callio Therapeutics | 2026-03-19 |
| A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases (NCT07412691) | BeOne Medicines | 2026-03-19 |
| A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity (NCT07476118) | Eli Lilly and Company | 2026-03-18 |
| Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. (NCT06947473) | Beijing GoBroad Hospital | 2026-03-18 |
| Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma (NCT06498648) | National Cancer Institute (NCI) | 2026-03-18 |
| Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia (NCT07453836) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2026-03-18 |
| Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers (NCT07463053) | Jemincare | 2026-03-18 |
| High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) (NCT07177079) | Kittika Poonsombudlert | 2026-03-18 |
| A Study of MG2512 Injection in Participants With Advanced Solid Tumors (NCT07348653) | Shanghai Mabgen Biopharmaceutical Technology Co., Ltd. | 2026-03-18 |
| A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction (NCT07465653) | Novartis Pharmaceuticals | 2026-03-18 |
| CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA (NCT07451236) | Chang Yingjun | 2026-03-18 |
| H3K27M-specific Immune Effector Cells Targeting DMG/DIPG (NCT07501156) | Shenzhen Geno-Immune Medical Institute | 2026-03-18 |
| A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005) (NCT07431866) | Merck Sharp & Dohme LLC | 2026-03-18 |
| Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer (NCT07501650) | Thomas Jefferson University | 2026-03-18 |
| Atamparib in Patients With Advanced Solid Tumors (NCT07374419) | Nerviano Medical Sciences (Shanghai) Ltd. | 2026-03-18 |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors (NCT07262164) | Shanghai Virogin Biotech Co., Ltd. | 2026-03-18 |
| One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors (NCT06781125) | Immorna Biotherapeutics, Inc. | 2026-03-18 |
| A Mutiple-dose Study of IBI3033 in Healthy Participants (NCT07456839) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-03-18 |
| A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors (NCT07540572) | IDEAYA Biosciences | 2026-03-17 |
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age (NCT07478952) | ModernaTX, Inc. | 2026-03-17 |
| Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours (NCT07446855) | AstraZeneca | 2026-03-17 |
| A Study of MHB009C in Patients With Advanced Solid Tumors (NCT07326488) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-03-17 |
| A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors (NCT07477743) | HC Biopharma Inc. | 2026-03-17 |
| First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors (NCT07362888) | Adcendo ApS | 2026-03-17 |
| Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma (NCT07529782) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-03-17 |
| Alnuctamab for Refractory SLE (LATTE Study) (NCT07219563) | Icahn School of Medicine at Mount Sinai | 2026-03-17 |
| Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma (NCT07200102) | Washington University School of Medicine | 2026-03-17 |
| CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL (NCT07294677) | University of Chicago | 2026-03-17 |
| Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor (NCT07484152) | University of Sao Paulo General Hospital | 2026-03-17 |
| Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization (NCT05264974) | University of Florida | 2026-03-17 |
| A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD) (NCT07431112) | AIRNA Corporation | 2026-03-17 |
| Safety, Tolerability and Pharmacokinetics of ETD-001 Gel (NCT07674862) | Etern Therapeutics Wuxi Limited | 2026-03-16 |
| Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD). (NCT07476872) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-16 |
| Modafinil to Improve Fatiguability (NCT05333250) | Ottawa Hospital Research Institute | 2026-03-16 |
| SAD and MAD Study of AKB-9090 in Healthy Adult Participants (NCT07429006) | Akebia Therapeutics | 2026-03-16 |
| cfMSC Therapy for Diabetes (NCT07495956) | Shenzhen Geno-Immune Medical Institute | 2026-03-16 |
| Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon (NCT07264790) | Duke University | 2026-03-16 |
| Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol (NCT07269873) | BioCorRx Pharmaceuticals Inc | 2026-03-16 |
| 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer (NCT07145177) | University of California, San Francisco | 2026-03-16 |
| A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects (NCT07414602) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-03-16 |
| A Phase I Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults (NCT07316608) | AstraZeneca | 2026-03-16 |
| A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokinetic Noninferiority of Empasiprubart SC Versus Intravenous (IV) in Healthy Adult Participants (NCT07612020) | argenx | 2026-03-16 |
| A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) (NCT07291076) | Bristol-Myers Squibb | 2026-03-16 |
| Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Locally Delivered Nanotherapeutic in the Treatment of Stage II Periodontitis (NCT07754253) | Mansoura University | 2026-03-16 |
| A Study of ORN252 in Healthy Participants (NCT07439796) | Orna Therapeutics, Inc. | 2026-03-16 |
| A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) (NCT07454863) | Dizal Pharmaceuticals | 2026-03-16 |
| A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. (NCT07366866) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-03-16 |
| A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment (NCT07445906) | Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. | 2026-03-15 |
| A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. (NCT07470853) | Whitehawk Therapeutics, Inc. | 2026-03-15 |
| Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma (NCT07454031) | Peking University | 2026-03-15 |
| Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome (NCT07481422) | University of Rijeka | 2026-03-15 |
| CE-STAND: Cervical Epidural STimulation After Neurologic Damage (NCT06410001) | University of Minnesota | 2026-03-15 |
| PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption (NCT07302698) | Aspargo Labs, Inc | 2026-03-15 |
| Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis (NCT07454772) | All India Institute of Medical Sciences, Bhubaneswar | 2026-03-15 |
| PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults (NCT07300007) | Aspargo Labs, Inc | 2026-03-15 |
| BY002 IIT Study in R/R Acute Leukemia (NCT07270770) | The First Affiliated Hospital of Soochow University | 2026-03-15 |
| A Single- and Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2059 Powder for Inhalation (NCT07510958) | InnovStone Therapeutics Limited | 2026-03-15 |
| Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome (NCT07150013) | Unravel Biosciences, Inc. | 2026-03-15 |
| A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants (NCT07460284) | Guangdong Raynovent Biotech Co., Ltd | 2026-03-15 |
| A Study of JSKN027 in Patients With Advanced Solid Tumors (NCT07391644) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2026-03-15 |
| Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment (NCT07472270) | Vinmec Research Institute of Stem Cell and Gene Technology | 2026-03-15 |
| Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects (NCT07476963) | Forward Pharmaceuticals Co., Ltd. | 2026-03-15 |
| Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia (NCT07486726) | Shanghai Jiao Tong University School of Medicine | 2026-03-15 |
| An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Pitt Hopkins Syndrome (NCT07150026) | Unravel Biosciences, Inc. | 2026-03-15 |
| Exploratory Clinical Study of TCR-T for MAGE-A4-positive Mesenchymal Malignancies (NCT07467122) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-03-15 |
| Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial (NCT06326008) | Beijing GoBroad Hospital | 2026-03-15 |
| Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma (NCT07476066) | Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd | 2026-03-15 |
| Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide (NCT07295873) | Beijing Continent Pharmaceutical Co, Ltd. | 2026-03-15 |
| A Study of Efimosfermin Alfa in Adults With Hepatic Impairment (NCT07358546) | GlaxoSmithKline | 2026-03-13 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants (NCT07371455) | Longwood Pharmaceuticals (Hangzhou) Co., Ltd. | 2026-03-13 |
| Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer (NCT06705686) | TechnoGenesys, Inc. | 2026-03-13 |
| A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants (NCT07444424) | AstraZeneca | 2026-03-13 |
| Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects (NCT07535099) | Beijing InnoCare Pharma Tech Co., Ltd. | 2026-03-13 |
| IL-17 Blockade to Decrease irAEs (REPLAY) (NCT07237594) | Duke University | 2026-03-12 |
| A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors (NCT07380334) | Jiangsu HengRui Medicine Co., Ltd. | 2026-03-12 |
| Study of BW-50218 in Healthy Participants (NCT07401472) | Shanghai Argo Biopharmaceutical Co., Ltd. | 2026-03-12 |
| Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults (NCT06862453) | Sanaria Inc. | 2026-03-12 |
| Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine (NCT07418372) | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2026-03-12 |
| A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors (NCT07469982) | Shouyao Holdings (Beijing) Co. LTD | 2026-03-12 |
| Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers (NCT07347678) | Ikaria Bioscience Pty Ltd | 2026-03-12 |
| The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG. (NCT07445308) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2026-03-12 |
| NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma (NCT07052305) | Washington University School of Medicine | 2026-03-12 |
| Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty (NCT07672301) | University of Chicago | 2026-03-11 |
| A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC (NCT07491497) | TRIANA Biomedicines, Inc. | 2026-03-11 |
| A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body (NCT07407348) | Boehringer Ingelheim | 2026-03-11 |
| Pemefolacianine for IMI of Lung Cancer (NCT07772895) | Sunil Singhal | 2026-03-11 |
| Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue (NCT07498218) | Ayu, Inc. | 2026-03-11 |
| A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer (NCT07481383) | Continuity Biosciences, LLC | 2026-03-11 |
| A Dose-Escalation Study of RO7875913 in Healthy Participants (NCT07342114) | Genentech, Inc. | 2026-03-11 |
| Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer (NCT07421700) | Pfizer | 2026-03-11 |